Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2012 Filed Aug 1, 2012 21:28 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,274 | $0.00 Strike: $52.23 | $0.00 |
DisclosureSEC source: 0001179110-12-012181 · edgar.xml · derivative · entry 4 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,274 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 21:28 UTC |
Warmuth Michael JSenior Vice President
|
Tax withholdingCommon shares without par value | 5,404 | $66.39 | $358,771.56 |
DisclosureSEC source: 0001179110-12-012181 · edgar.xml · nonDerivative · entry 2 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,625 Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 21:28 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionCommon shares without par value | 6,274 | $52.23 | $327,691.02 |
DisclosureSEC source: 0001179110-12-012181 · edgar.xml · nonDerivative · entry 1 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 21:27 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 18,043 | $0.00 Strike: $66.39 | $0.00 |
DisclosureSEC source: 0001179110-12-012179 · edgar.xml · derivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,043 Underlying: Common shares · 18,043 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 21:27 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,565 | $0.00 Strike: $52.49 | $0.00 |
DisclosureSEC source: 0001179110-12-012179 · edgar.xml · derivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,565 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 21:27 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 14,991 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001179110-12-012179 · edgar.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 14,991 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 21:27 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon shares without par value | 18,043 | $66.39 | $1,197,874.77 |
DisclosureSEC source: 0001179110-12-012179 · edgar.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,063 Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 21:27 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 5,565 | $52.49 | $292,106.85 |
DisclosureSEC source: 0001179110-12-012179 · edgar.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 21:27 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 14,991 | $52.55 | $787,777.05 |
DisclosureSEC source: 0001179110-12-012179 · edgar.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 21:29 UTC |
ALBAN CARLOSSenior Vice President
|
SaleCommon shares without par value | 352 | $66.62 | $23,451.30 |
DisclosureSEC source: 0001179110-12-012182 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,817 Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,538 | $0.00 Strike: $56.98 | $0.00 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · derivative · entry 10 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,538 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 30,800 | $0.00 Strike: $41.48 | $0.00 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · derivative · entry 9 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 30,800 shares Expires 2016-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,200 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · derivative · entry 8 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,200 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 7,299 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · derivative · entry 7 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 7,299 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
SaleCommon shares without par value | 1,538 | $66.00 | $101,508.00 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · nonDerivative · entry 6 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,169 Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
SaleCommon shares without par value | 43,299 | $65.00 | $2,814,435.00 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · nonDerivative · entry 5 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,707 Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,538 | $56.98 | $87,635.24 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · nonDerivative · entry 4 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionCommon shares without par value | 30,800 | $41.48 | $1,277,584.00 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · nonDerivative · entry 3 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,200 | $44.16 | $229,632.00 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:05 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionCommon shares without par value | 7,299 | $46.34 | $338,235.66 |
DisclosureSEC source: 0001179110-12-011966 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:08 UTC |
Warmuth Michael JSenior Vice President
|
GrantOption (right to buy) · Derivative | 3,103 | $0.00 Strike: $65.06 | $0.00 |
DisclosureSEC source: 0001179110-12-011781 · edgar.xml · derivative · entry 5 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,103 Underlying: Common shares · 3,103 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:08 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,572 | $0.00 Strike: $51.91 | $0.00 |
DisclosureSEC source: 0001179110-12-011781 · edgar.xml · derivative · entry 4 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,572 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:08 UTC |
Warmuth Michael JSenior Vice President
|
Tax withholdingCommon shares without par value | 3,103 | $65.06 | $201,881.18 |
DisclosureSEC source: 0001179110-12-011781 · edgar.xml · nonDerivative · entry 2 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,755 Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:08 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,572 | $51.91 | $185,422.52 |
DisclosureSEC source: 0001179110-12-011781 · edgar.xml · nonDerivative · entry 1 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:30 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001179110-12-011782 · edgar.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,000 Underlying: Common shares · 30,000 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:30 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 24,357 | $65.06 | $1,584,666.42 |
DisclosureSEC source: 0001179110-12-011782 · edgar.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,086 Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:30 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 30,000 | $44.16 | $1,324,800.00 |
DisclosureSEC source: 0001179110-12-011782 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:39 UTC |
ALBAN CARLOSSenior Vice President
|
GrantOption (right to buy) · Derivative | 2,482 | $0.00 Strike: $65.06 | $0.00 |
DisclosureSEC source: 0001179110-12-011783 · edgar.xml · derivative · entry 6 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,482 Underlying: Common shares · 2,482 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:39 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,834 | $0.00 Strike: $51.28 | $0.00 |
DisclosureSEC source: 0001179110-12-011783 · edgar.xml · derivative · entry 5 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,834 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:39 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,601 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001179110-12-011783 · edgar.xml · derivative · entry 4 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,601 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:39 UTC |
ALBAN CARLOSSenior Vice President
|
Tax withholdingCommon shares without par value | 4,334 | $65.06 | $281,970.04 |
DisclosureSEC source: 0001179110-12-011783 · edgar.xml · nonDerivative · entry 3 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,169 Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:39 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,834 | $51.28 | $145,327.52 |
DisclosureSEC source: 0001179110-12-011783 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2012 Filed Jul 25, 2012 21:39 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,601 | $46.34 | $120,530.34 |
DisclosureSEC source: 0001179110-12-011783 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2012 Filed Jul 3, 2012 21:11 UTC |
OSBORN WILLIAM ADirector
|
GrantStock Equivalent Units · Derivative | 519 | $64.47 Strike: $0.00 | $33,459.93 |
DisclosureSEC source: 0001179110-12-011153 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,137 Underlying: Common shares · 519 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2012 Filed Jul 3, 2012 21:17 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 511 | $64.47 Strike: $0.00 | $32,944.17 |
DisclosureSEC source: 0001179110-12-011154 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,276 Underlying: Common shares · 511 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2012 Filed Jul 3, 2012 21:18 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 511 | $64.47 Strike: $0.00 | $32,944.17 |
DisclosureSEC source: 0001179110-12-011155 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,813 Underlying: Common shares · 511 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2012 Filed Jul 3, 2012 21:18 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 122 | $64.47 Strike: $0.00 | $7,865.34 |
DisclosureSEC source: 0001179110-12-011156 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,153 Underlying: Common shares · 122 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 29, 2012 Filed Jul 3, 2012 21:18 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,275 | $0.00 Strike: $50.95 | $0.00 |
DisclosureSEC source: 0001179110-12-011157 · edgar.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,275 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| June 29, 2012 Filed Jul 3, 2012 21:18 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 2,275 | $64.42 | $146,557.78 |
DisclosureSEC source: 0001179110-12-011157 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,795 Read SEC document |
| June 29, 2012 Filed Jul 3, 2012 21:18 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,275 | $50.95 | $115,911.25 |
DisclosureSEC source: 0001179110-12-011157 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 165 | $0.00 Strike: $62.70 | $0.00 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · derivative · entry 24 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165 Underlying: Common shares · 165 shares Expires 2013-02-12 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 6,408 | $0.00 Strike: $62.70 | $0.00 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · derivative · entry 23 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,408 Underlying: Common shares · 6,408 shares Expires 2013-08-31 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 187 | $0.00 Strike: $50.03 | $0.00 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · derivative · entry 22 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 187 shares Expires 2013-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 7,268 | $0.00 Strike: $50.03 | $0.00 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · derivative · entry 21 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 7,268 shares Expires 2013-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
Tax withholdingCommon shares without par value | 6,573 | $62.70 | $412,127.10 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · nonDerivative · entry 20 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,034 Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 7,455 | $50.03 | $372,973.65 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · nonDerivative · entry 19 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 3,665 | $62.76 | $230,015.40 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · nonDerivative · entry 18 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,152 Read SEC document |
| June 18, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 600 | $62.76 | $37,653.00 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · nonDerivative · entry 17 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,817 Read SEC document |
| June 18, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 2,900 | $62.75 | $181,975.00 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · nonDerivative · entry 16 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,417 Read SEC document |
| June 18, 2012 Filed Jun 20, 2012 21:16 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 2,000 | $62.75 | $125,490.00 |
DisclosureSEC source: 0001179110-12-010603 · edgar.xml · nonDerivative · entry 15 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,317 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.